Zentalis Pharmaceuticals Llc (ZNTL)
Healthcare
Biotechnology
4.70 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Zentalis Pharmaceuticals Llc (ZNTL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.2% of the shares are freely tradable; institutional investors hold 62.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
62.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
22.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
68.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
71Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Squadron Capital Management LLC | 5.66 | 4,031,000 | +0.0 | 03/31/2026 |
| 5AM Venture Management, LLC | 5.55 | 3,947,913 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 4.15 | 2,956,526 | +100.9 | 03/31/2026 |
| Vanguard Group Inc | 4.01 | 2,855,590 | -1.7 | 12/31/2025 |
| Acadian Asset Management LLC | 4.00 | 2,848,252 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.25 | 2,310,707 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 2.72 | 1,938,145 | -32.8 | 03/31/2026 |
| Citadel Advisors Llc | 2.43 | 1,732,083 | -11.8 | 03/31/2026 |
| D. E. Shaw & Co LP | 2.08 | 1,484,098 | -10.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.66 | 1,890,849 | +11.6 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.